TWO SIGMA INVESTMENTS, LP - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$19,197
+6.6%
12,149
-16.3%
0.00%
Q3 2022$18,000
-48.6%
14,518
-15.8%
0.00%
Q2 2022$35,000
-72.0%
17,249
-65.5%
0.00%
Q1 2022$125,000
-76.2%
50,068
-64.5%
0.00%
-100.0%
Q4 2021$525,000
+76.2%
140,857
+89.6%
0.00%0.0%
Q3 2021$298,00074,2800.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders